Extremely Low Prevalence of Amyloid Positron Emission Tomography Positivity in Parkinson's Disease without Dementia

Kyoko Mashima, Daisuke Ito, Masashi Kameyama, Takashi Osada, Hajime Tabuchi, Yoshihiro Nihei, Takahito Yoshizaki, Eri Noguchi, Mariko Tanikawa, Takashi Iizuka, Yugaku Date, Yuji Ogata, Tadaki Nakahara, Yu Iwabuchi, Masahiro Jinzaki, Koji Murakami, Norihiro Suzuki

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Background: Most cases of dementia with Lewy bodies (DLB) show Alzheimer's disease pathology-like senile plaques and neurofibrillary tangles. Several studies have also revealed a high prevalence of positive amyloid imaging with positron emission tomography (PET) in DLB and moderate prevalence in Parkinson's disease (PD) with dementia. However, it remains unclear in PD without dementia as to when the brain β amyloid (Aβ) burden begins and progresses. Our study aimed to determine the prevalence of Aβ deposition in PD without dementia using amyloid PET. Methods: This was a cross-sectional study on 33 patients with PD without dementia, of whom 21 had normal cognition and 12 met the criteria for PD-mild cognitive impairment. All subjects underwent neuropsychological assessment and [18F] florbetaben (FBB) PET. Results: All subjects had Lewy body-related disorders, displaying a significantly reduced myocardial [123I] metaiodobenzylguanidine uptake. The cortical FBB-binding pattern in all subjects, including APOE e4 carriers, suggested negative Aβ deposition. Conclusion: Patients with PD without dementia exhibit an extremely low prevalence of Aβ positivity compared with those reported in cognitively normal elderly controls. Further longitudinal imaging studies and long-term follow-up are needed; however, our findings provide novel insights for understanding Aβ metabolism in PD.

Original languageEnglish
Pages (from-to)231-237
Number of pages7
JournalEuropean Neurology
DOIs
Publication statusAccepted/In press - 2017 Mar 11

Fingerprint

Amyloid
Positron-Emission Tomography
Parkinson Disease
Dementia
Lewy Body Disease
Lewy Bodies
Neurofibrillary Tangles
Amyloid Plaques
Cognition
Longitudinal Studies
Alzheimer Disease
Cross-Sectional Studies
Pathology
Brain

Keywords

  • Alzheimer’s disease
  • Amyloid imaging
  • Dementia
  • Florbetaben
  • Mild cognitive impairment
  • Parkinson’s disease
  • Positron emission tomography
  • β amyloid

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Extremely Low Prevalence of Amyloid Positron Emission Tomography Positivity in Parkinson's Disease without Dementia. / Mashima, Kyoko; Ito, Daisuke; Kameyama, Masashi; Osada, Takashi; Tabuchi, Hajime; Nihei, Yoshihiro; Yoshizaki, Takahito; Noguchi, Eri; Tanikawa, Mariko; Iizuka, Takashi; Date, Yugaku; Ogata, Yuji; Nakahara, Tadaki; Iwabuchi, Yu; Jinzaki, Masahiro; Murakami, Koji; Suzuki, Norihiro.

In: European Neurology, 11.03.2017, p. 231-237.

Research output: Contribution to journalArticle

Mashima, Kyoko ; Ito, Daisuke ; Kameyama, Masashi ; Osada, Takashi ; Tabuchi, Hajime ; Nihei, Yoshihiro ; Yoshizaki, Takahito ; Noguchi, Eri ; Tanikawa, Mariko ; Iizuka, Takashi ; Date, Yugaku ; Ogata, Yuji ; Nakahara, Tadaki ; Iwabuchi, Yu ; Jinzaki, Masahiro ; Murakami, Koji ; Suzuki, Norihiro. / Extremely Low Prevalence of Amyloid Positron Emission Tomography Positivity in Parkinson's Disease without Dementia. In: European Neurology. 2017 ; pp. 231-237.
@article{9a09908703c741f2b8ce173085cce231,
title = "Extremely Low Prevalence of Amyloid Positron Emission Tomography Positivity in Parkinson's Disease without Dementia",
abstract = "Background: Most cases of dementia with Lewy bodies (DLB) show Alzheimer's disease pathology-like senile plaques and neurofibrillary tangles. Several studies have also revealed a high prevalence of positive amyloid imaging with positron emission tomography (PET) in DLB and moderate prevalence in Parkinson's disease (PD) with dementia. However, it remains unclear in PD without dementia as to when the brain β amyloid (Aβ) burden begins and progresses. Our study aimed to determine the prevalence of Aβ deposition in PD without dementia using amyloid PET. Methods: This was a cross-sectional study on 33 patients with PD without dementia, of whom 21 had normal cognition and 12 met the criteria for PD-mild cognitive impairment. All subjects underwent neuropsychological assessment and [18F] florbetaben (FBB) PET. Results: All subjects had Lewy body-related disorders, displaying a significantly reduced myocardial [123I] metaiodobenzylguanidine uptake. The cortical FBB-binding pattern in all subjects, including APOE e4 carriers, suggested negative Aβ deposition. Conclusion: Patients with PD without dementia exhibit an extremely low prevalence of Aβ positivity compared with those reported in cognitively normal elderly controls. Further longitudinal imaging studies and long-term follow-up are needed; however, our findings provide novel insights for understanding Aβ metabolism in PD.",
keywords = "Alzheimer’s disease, Amyloid imaging, Dementia, Florbetaben, Mild cognitive impairment, Parkinson’s disease, Positron emission tomography, β amyloid",
author = "Kyoko Mashima and Daisuke Ito and Masashi Kameyama and Takashi Osada and Hajime Tabuchi and Yoshihiro Nihei and Takahito Yoshizaki and Eri Noguchi and Mariko Tanikawa and Takashi Iizuka and Yugaku Date and Yuji Ogata and Tadaki Nakahara and Yu Iwabuchi and Masahiro Jinzaki and Koji Murakami and Norihiro Suzuki",
year = "2017",
month = "3",
day = "11",
doi = "10.1159/000464322",
language = "English",
pages = "231--237",
journal = "European Neurology",
issn = "0014-3022",
publisher = "S. Karger AG",

}

TY - JOUR

T1 - Extremely Low Prevalence of Amyloid Positron Emission Tomography Positivity in Parkinson's Disease without Dementia

AU - Mashima, Kyoko

AU - Ito, Daisuke

AU - Kameyama, Masashi

AU - Osada, Takashi

AU - Tabuchi, Hajime

AU - Nihei, Yoshihiro

AU - Yoshizaki, Takahito

AU - Noguchi, Eri

AU - Tanikawa, Mariko

AU - Iizuka, Takashi

AU - Date, Yugaku

AU - Ogata, Yuji

AU - Nakahara, Tadaki

AU - Iwabuchi, Yu

AU - Jinzaki, Masahiro

AU - Murakami, Koji

AU - Suzuki, Norihiro

PY - 2017/3/11

Y1 - 2017/3/11

N2 - Background: Most cases of dementia with Lewy bodies (DLB) show Alzheimer's disease pathology-like senile plaques and neurofibrillary tangles. Several studies have also revealed a high prevalence of positive amyloid imaging with positron emission tomography (PET) in DLB and moderate prevalence in Parkinson's disease (PD) with dementia. However, it remains unclear in PD without dementia as to when the brain β amyloid (Aβ) burden begins and progresses. Our study aimed to determine the prevalence of Aβ deposition in PD without dementia using amyloid PET. Methods: This was a cross-sectional study on 33 patients with PD without dementia, of whom 21 had normal cognition and 12 met the criteria for PD-mild cognitive impairment. All subjects underwent neuropsychological assessment and [18F] florbetaben (FBB) PET. Results: All subjects had Lewy body-related disorders, displaying a significantly reduced myocardial [123I] metaiodobenzylguanidine uptake. The cortical FBB-binding pattern in all subjects, including APOE e4 carriers, suggested negative Aβ deposition. Conclusion: Patients with PD without dementia exhibit an extremely low prevalence of Aβ positivity compared with those reported in cognitively normal elderly controls. Further longitudinal imaging studies and long-term follow-up are needed; however, our findings provide novel insights for understanding Aβ metabolism in PD.

AB - Background: Most cases of dementia with Lewy bodies (DLB) show Alzheimer's disease pathology-like senile plaques and neurofibrillary tangles. Several studies have also revealed a high prevalence of positive amyloid imaging with positron emission tomography (PET) in DLB and moderate prevalence in Parkinson's disease (PD) with dementia. However, it remains unclear in PD without dementia as to when the brain β amyloid (Aβ) burden begins and progresses. Our study aimed to determine the prevalence of Aβ deposition in PD without dementia using amyloid PET. Methods: This was a cross-sectional study on 33 patients with PD without dementia, of whom 21 had normal cognition and 12 met the criteria for PD-mild cognitive impairment. All subjects underwent neuropsychological assessment and [18F] florbetaben (FBB) PET. Results: All subjects had Lewy body-related disorders, displaying a significantly reduced myocardial [123I] metaiodobenzylguanidine uptake. The cortical FBB-binding pattern in all subjects, including APOE e4 carriers, suggested negative Aβ deposition. Conclusion: Patients with PD without dementia exhibit an extremely low prevalence of Aβ positivity compared with those reported in cognitively normal elderly controls. Further longitudinal imaging studies and long-term follow-up are needed; however, our findings provide novel insights for understanding Aβ metabolism in PD.

KW - Alzheimer’s disease

KW - Amyloid imaging

KW - Dementia

KW - Florbetaben

KW - Mild cognitive impairment

KW - Parkinson’s disease

KW - Positron emission tomography

KW - β amyloid

UR - http://www.scopus.com/inward/record.url?scp=85015618279&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85015618279&partnerID=8YFLogxK

U2 - 10.1159/000464322

DO - 10.1159/000464322

M3 - Article

C2 - 28285306

AN - SCOPUS:85015618279

SP - 231

EP - 237

JO - European Neurology

JF - European Neurology

SN - 0014-3022

ER -